RTRoberta Magalhães Tarantino

Roberta Magalhães Tarantino

*This is an algorithmically generated author record based on publicly available information.

Roberta Magalhães Tarantino has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unveiling the mechanisms of glucokinase variants implicated in human disease through molecular dynamics simulations

    by Ritiele Bastos de Souza, Deborah Antunes dos Santos, Gabriella de Medeiros Abreu, Roberta Magalhães Tarantino, Ana Carolina Proença da Fonseca, Verônica Marques Zembrzuski, Pedro Hernán Cabello, Ana Carolina Ramos Guimarães, Mário Campos Junior

  • Open Access

    Identification of the First PAX4-MODY Family Reported in Brazil

    by Gabriella de Medeiros Abreu, Camila de Almeida Pereira Dias Soares, Roberta Magalhães Tarantino, Ana Carolina Proença da Fonseca, Ritiele Bastos de Souza, Maria de Fátima Carvalho Pereira, Pedro Hernan Cabello, Melanie Rodacki, Lenita Zajdenverg, Verônica Marques Zembrzuski, et al.

    Purpose: The aim of this study was to sequence the coding region of the PAX4 gene in a Brazilian cohort with clinical manifestations of monogenic diabetes. Patients and Methods: This study included 31 patients with autosomal dominant history of diabetes, age at diagnosis ≤ 40 years, BMI < 30 kg/m2, and no mutations in GCK or HNF1A, HNF4A, and HNF1B. Screening of the PAX4 coding region was performed by Sanger sequencing. In silico algorithms were used to assess the potential impact of amino acid substitutions on protein structure and function. Additionally, PAX4-MODY family members and 158 control subjects without diabetes were analyzed for the identified mutation. Results: The molecular analysis of PAX4 has detected one missense mutation, p.Arg164Gln (c.491G>A), segregating with diabetes in a large Brazilian family. The mutation was absent among the control group. The index case is a woman diagnosed at 32 years of age with polyneuropathy and treated with insulin. She did not present diabetic renal disease or retinopathy. Family members with the PAX4 p.Arg164Gln mutation have a heterogeneous clinical manifestation and treatment response, with age at diagnosis ranging from 24 years to 50 years. Conclusion: To the best of our knowledge, this is the first study to report a PAX4-MODY family in Brazil. The age of PAX4-MODY diagnosis in the Brazilian family seems to be higher than the classical criteria for MODY. Our results reinforce the importance of screening large monogenic diabetes families for the understanding of the clinical manifestations of rare forms of diabetes for the specific and personalized treatment.


  • Open Access

    The first case of NEUROD1‐MODY reported in Latin America

    by Gabriella de Medeiros Abreu, Roberta Magalhães Tarantino, Pedro Hernan Cabello, Verônica Marques Zembrzuski, Ana Carolina Proença da Fonseca, Melanie Rodacki, Lenita Zajdenverg, Mário Campos Junior

    Background: MODY‐NEUROD1 is a rare form of monogenic diabetes caused by mutations in Neuronal differentiation 1 (NEUROD1). Until now, only a few cases of MODY‐NEUROD1 have been reported worldwide and the real contribution of mutations in NEUROD1 in monogenic diabetes and its clinical impact remain unclear.Methods: Genomic DNA was isolated from peripheral blood lymphocytes of 25 unrelated Brazilians patients with clinical characteristics suggestive of monogenic diabetes and the screening of the entire coding region of NEUROD1 was performed by Sanger sequencing.Results: We identified one novel frameshift deletion (p.Phe256Leufs*2) in NEUROD1 segregating in an autosomal dominant inheritance fashion. Almost 20 years after the first report of NEUROD1‐MODY, only a few families in Europe and Asia had shown mutations in NEUROD1 as the cause of monogenic diabetes.Conclusion: To our knowledge, we described the first case of NEUROD1‐MODY in a Latin American family.


  • Open Access

    MODY probability calculator for GCK and HNF1A screening in a multiethnic background population

    by Roberta Magalhães Tarantino, Gabriella de Medeiros Abreu, Ana Carolina Proença de Fonseca, Rosane Kupfer, Maria de Fátima Carvalho Pereira, Mario Campos, Lenita Zajdenverg, Melanie Rodacki

    Key words: GCK; HNF1A; MODY; monogenic diabetes